Session Three of Defeat Duchenne Canadian Conference Addressing Standards of Care in Canada to Take Place December 3rd and 4th

The NMD4C is proud to partner with Jesse’s Journey and Muscular Dystrophy Canada (MDC) in hosting the first national summit solely focused on DMD for health care providers across Canada, with the theme for this year’s event being ‘Addressing DMD Standards of Care in Canada’. We have brought together subject matter experts from pediatric and adult care for a comprehensive overview of the Canadian adaptation to the international DMD care considerations published in 2018.

Don’t forget to register for the third and final session of the CPD-accredited Defeat Duchenne Canadian Conference, which will take place on the 3rd and 4th of December, 2021 with sessions on Orthopedic Management and Rehabilitation Management in Duchenne on December 3rd, and Psychosocial Management and Duchenne and the Brain on December 4th.

Thank you to everyone from our community who completed the pre-event Canadian Duchenne standards of care survey. The results from the survey will be used as a springboard for discussion during the event and prepared for publication thereafter. We hope to see you at the conference!

Register for session three here!

 

 

Day 1: Friday, December 3, 2021

11 a.m. – 12:30 p.m. ET: Orthopedic Management in Duchenne

Moderator:

Co-Leads/Speakers:

  • Dr. Chris Reilly (Pediatric Orthopedic Surgeon)
  • Dr. Patricia Larouche (Pediatric Orthopedic Surgeon)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in orthopedic management across Canada.
  • Understand lived experience of orthopedic care from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care for orthopedic care.

 

12:30 – 2 p.m. ET: Rehabilitation Management in Duchenne

Moderator:

Co-Leads/Speakers:

  • Dr. Sue Dojeiji (Adult Physiatrist)
  • Dr. Jordan Sheriko (Medical Director of Pediatric Rehabilitation)

Speakers:

  • Dr. Anna McCormick (Pediatrician & Pediatric Physiatrist)
  • Charise MacDonald (Occupational Therapist)
  • Dr. Michael Berger (Adult Physiatrist)

Panelists:

  • Sarah Moore (Recreational Therapist)
  • Khalid Mahdi (DMD Adult)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in rehabilitation management.
  • Understand lived experience of rehabilitation services from people with Duchenne and their families.
  • Participate in insightful discussions to identify and provide recommendations on how to address current gaps in Duchenne standards of care in rehabilitation management.

 

Day 2: Saturday, December 4, 2021

11 a.m. – 12:30 p.m. ET: Duchenne and the Brain

Moderator/Lead:

Speakers:

  • Dr. Francesco Muntoni (Professor Pediatric Neurology) – Keynote Speaker
  • Dr. Veronica Hinton (Professor of Psychology)

Panelists:

  • Debra Chiabai (DMD Parent)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care involving the brain across Canada.
  • Understand lived experience involving the brain from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care involving the brain.

 

12:30 – 2 p.m. ET: Psychosocial Management

Moderator:

Co-Leads/Speakers:

  • Dr. Jean Mah (Pediatric Neurologist)
  • Dr. Stephanie Plamondon (Adult Physiatrist)

Panelist:

  • Debra Chiabai (DMD Parent)
  • Zoe Schwartz (Pediatric Social Worker)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in psychosocial management across Canada.
  • Understand lived experience of psychosocial management from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care for psychosocial management.
DDCC21_speakers_poster

Read next...

2025 clinical and research fellowships competition from NMD4C and MDC.

Fourth Annual Clinical & Postdoctoral Fellowship Competition from NMD4C, MDC to Open Fall 2024

NMD4C together with Muscular Dystrophy Canada are excited to announce that our annual Neuromuscular Fellowship Competition will open again for a fourth year on September 3, 2024!

NMD4C wraps up 2023-2024 neuromuscular clinical training curriculum

NMD4C Wraps up Second Year of Training Series for Canadian Neuromuscular Clinical Fellows

We’re excited to share that the second annual National Neuromuscular Lecture Series (NNLS) finished last week!

2024 NMD4C basic research summer school. Photo of attendees on the right.

NMD4C Host Inaugural Basic Research Summer School

Over May 27-28 2024, the NMD4C animal and cell-based research team hosted the first-ever annual basic research summer school for neuromuscular research trainees at McGill University in Montréal, QC. 

NMD4C investigator Dr Reshma Amin receives funding from CIHR for a grant to develop a framework for real-world evidence for NMDs in Canada

NMD4C Investigator Dr. Reshma Amin Leads Successful CIHR Grant Application to Establish a Framework for Real-World Evidence for Canadian Neuromuscular Diseases

Real-World Evidence for Canadian Neuromuscular Disease: Establishing a Framework for National Integration of Patient Reported Outcomes, Clinical Registry Data, Healthcare Utilization and Healthcare Associated Costs   The NMD4C is excited to share that network investigator Dr. Reshma Amin has been awarded funding from the CIHR to establish a framework for real-world evidence (RWE) for Canadian…

Spinal muscular atrophy outcome measures training registration open for December 3rd event.

Spinal Muscular Atrophy Outcome Measures Workshop (English Language)

The NMD4C will be hosting an English-language interactive training workshop on standardizing assessment practices in SMA outcome measures. 

Canadian Neuromuscular Community of Practice

NMD4C Launch Survey to Assess Familiarity and Experience in Outcome Measures in NMDs

As we anticipate novel treatments for other neuromuscular conditions, we would like to understand your familiarity and experience with the outcome measures in clinical trials underway or for treatments for NMDs approved in other jurisdictions through a short survey.